We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
High-quality evidence was lacking for most of the COVID-19 diagnostics, medical devices and drugs the FDA has granted Emergency Use Authorization (EUA) since the start of the pandemic, claimed researchers at Israel’s Tel-Aviv University in a provocative analysis in the journal JAMA Internal Medicine. Read More
The FDA yesterday granted de novo marketing approval to Philips’ CavaClear laser sheath, the first laser-based device approved for the removal of inferior vena cava (IVC) filters when previous removal methods have failed. Read More
UK-based Motilent has partnered with Nuance Communications, a Microsoft subsidiary based in Burlington, Mass., that markets AI software and speech recognition products. Read More